drugset / Trial / NCT01379521
Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC
RandomizedSingle-groupQuadruple-blindTreatment
Summary
This study will evaluate the role of everolimus in combination with local Transcatheter Arterial Chemoembolization (TACE) procedure in patients with localized unresectable Hepatocellular Carcinoma (HCC).
Timeline
- Start
- 2011-06
- Primary completion
- 2015-06
- Completion
- 2015-06
Outcome
Outcome not reported
Stopped (Enrollment): “The study was terminated due to low enrollment. This resulted in the study being underpowered and inconclusive.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | 7.5 mg | Oral |